What is LENZ Therapeutics Inc (LENZ) stock price today?

LENZ Therapeutics Inc (LENZ) currently trades at $8.98 per share. The stock has a market capitalization of $306.02M and a P/E ratio of —x.

Is LENZ stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, LENZ Therapeutics Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is LENZ Therapeutics Inc's revenue and earnings?

LENZ Therapeutics Inc has trailing twelve-month (TTM) revenue of $19.09M with profit margins of 0.00%. Earnings per share (EPS) is $-2.85.

LENZ

LENZ Therapeutics Inc

NASDAQ: LENZ · HEALTHCARE · BIOTECHNOLOGY

$8.98

-0.77% today

Updated 2026-04-30

Market cap

$306.02M

P/E ratio

—

P/S ratio

16.03x

EPS (TTM)

$-2.85

Dividend yield

—

52W range

$8 – $50

Volume

0.9M

Market cap

$306.02M

P/E ratio

—

P/S ratio

16.03x

EPS (TTM)

$-2.85

Dividend yield

—

52W range

$8 – $50

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$39.57

+340.65%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-33.06M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$15.00M	$0.00	$0.00	$19.09M	$19.09M
Net income	$-10.81M	$-69.97M	$-49.77M	$-82.13M	$-35.90M
EPS	—	—	—	—	$-2.85
Free cash flow	$-94.57M	$-60.41M	$-59.86M	$-70.00M	$-33.06M
Profit margin	-72.07%	—	—	-430.25%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LENZ	$306.02M	30	4.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

LENZ Therapeutics Inc trades at $8.98. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $19.09M.

Frequently asked questions

What is LENZ Therapeutics Inc's stock price?

LENZ Therapeutics Inc (LENZ) trades at $8.98.

Is LENZ Therapeutics Inc overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of LENZ Therapeutics Inc (LENZ)?

The analyst target price is $39.57, representing +340.6% upside from the current price of $8.98.

What is LENZ Therapeutics Inc's revenue?

TTM revenue is $19.09M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio16.03x

ROE-33.60%

Beta2.30

50D MA$10.92

200D MA$25.12

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LENZ vs LLY →LENZ vs JNJ →LENZ vs ABBV →Stock screener →